Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lemoli

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursorsA Curti, M Fogli, M Ratta, et al.
Progress in Clinical and Biological Research|January 1, 1990
Photoradiation methods for purging autologous bone marrow graftsS Gulati, J Atzpodien, R M Lemoli, et al.
Cancer Communications|January 1, 1990
Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119R M Lemoli, S C Gulati, A Perez, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cellsM S Czuczman, P Garin-Chesa, R M Lemoli, et al.
International Journal of Cell Cloning|September 1, 1988
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutininG Visani, R M Lemoli, A Dinota, et al.
Journal of Biological Regulators and Homeostatic Agents|June 5, 2001
Dendritic cell differentiation from hematopoietic CD34+ progenitor cellsA Curti, M Fogli, M Ratta, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodiesS C Gulati, C Shimazaki, R M Lemoli, et al.
Experimental Hematology|December 1, 1992
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitroR M Lemoli, A Strife, B D Clarkson, et al.
Current Opinion in Oncology|April 1, 1992
Purging in autologous and allogeneic bone marrow transplantationS C Gulati, R M Lemoli, L Acaba, et al.
Haematologica|March 1, 1991
CD34 or S313 positive cells selection by avidin-biotin immunoadsorptionC Tassi, A Fortuna, A Bontadini, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursorsA Curti, M Fogli, M Ratta, et al.
Progress in Clinical and Biological Research|January 1, 1990
Photoradiation methods for purging autologous bone marrow graftsS Gulati, J Atzpodien, R M Lemoli, et al.
Cancer Communications|January 1, 1990
Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119R M Lemoli, S C Gulati, A Perez, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cellsM S Czuczman, P Garin-Chesa, R M Lemoli, et al.
International Journal of Cell Cloning|September 1, 1988
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutininG Visani, R M Lemoli, A Dinota, et al.
Journal of Biological Regulators and Homeostatic Agents|June 5, 2001
Dendritic cell differentiation from hematopoietic CD34+ progenitor cellsA Curti, M Fogli, M Ratta, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodiesS C Gulati, C Shimazaki, R M Lemoli, et al.
Experimental Hematology|December 1, 1992
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitroR M Lemoli, A Strife, B D Clarkson, et al.
Current Opinion in Oncology|April 1, 1992
Purging in autologous and allogeneic bone marrow transplantationS C Gulati, R M Lemoli, L Acaba, et al.
Haematologica|March 1, 1991
CD34 or S313 positive cells selection by avidin-biotin immunoadsorptionC Tassi, A Fortuna, A Bontadini, et al.
Pageof 10